Talaris Therapeutics Inc. (TALS)
NASDAQ: TALS
· Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Oct 19, 2023, 10:00 PM
Talaris Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -23.09M | -22.97M | -28.96M | -20.18M | n/a | -7.01M | -14.74M | -22.5M | -18.53M | -19.01M | -18.1M | -18.26M | -14.24M | -12.94M | -11.35M | -9.3M |
Depreciation & Amortization | 12K | 12K | -861K | 10K | n/a | n/a | 261K | 639K | 553K | 570K | 551K | 488K | 188K | 167K | 133K | 135K |
Stock-Based Compensation | 2.47M | 2.27M | 1.76M | 3.07M | 416K | n/a | 1.17M | 3.66M | 3.07M | 3.04M | 2.85M | 2.2M | 994K | 1.05M | 896K | 835K |
Other Working Capital | n/a | n/a | n/a | 485.68K | n/a | n/a | -418K | 414K | 146K | 2.4M | -1.65M | -1.46M | 2.1M | 1.8M | -1.64M | -1.27M |
Other Non-Cash Items | 350K | -994K | -26.87M | -8.19M | n/a | 7.01M | 14.74M | 1.45M | -992K | -294K | -95K | 3K | 16K | 76K | 484K | 553K |
Deferred Income Tax | n/a | n/a | 15.28M | n/a | n/a | n/a | -15.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 109K | 193K |
Change in Working Capital | n/a | n/a | 980K | 1.84M | n/a | n/a | -831K | -149K | 2.02M | 2.27M | -2.49M | -709K | 3.21M | 1.52M | -1.14M | -1.27M |
Operating Cash Flow | -20.26M | -21.68M | -38.67M | -23.44M | n/a | -7.01M | -14.68M | -16.9M | -13.87M | -13.43M | -17.28M | -16.28M | -9.83M | -10.13M | -10.98M | -9.05M |
Capital Expenditures | -7K | -9K | 532K | n/a | n/a | n/a | -221K | -320K | -269K | -341K | -1.09M | -1.34M | -1.19M | -726K | -335K | -187K |
Cash Acquisitions | n/a | n/a | 36.87K | n/a | n/a | n/a | -9.14K | -27.73K | -9.28K | -6.64K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -40.45M | -85.16M | -291.51M | -88.05M | n/a | n/a | -49.36M | -25.27M | -50.99M | -52.6M | -48M | -39.98M | -65.09M | -35.95M | -140.55M | -34.3M |
Sales Maturities Of Investments | 56.76M | 111.11M | 60.34M | 76.35M | n/a | n/a | 58.5M | 53M | 60.27M | 59.25M | 69.02M | 61.75M | 67M | 38.37M | 40.75M | 35.81M |
Other Investing Acitivies | n/a | n/a | -36.87K | n/a | n/a | n/a | 9.14K | 27.73K | 9.28K | 6.64K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 16.3M | 25.94M | -230.63M | -11.7M | n/a | n/a | 8.92M | 27.41M | 9.01M | 6.3M | 19.93M | 20.43M | 721K | 1.69M | -100.13M | 1.33M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 5.00 | n/a | n/a | n/a | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 54K | 562K | 161.16M | -1K | n/a | n/a | 137K | 46K | 60K | 73K | 79K | 30K | 412K | -551K | 137.52M | 17K |
Financial Cash Flow | 54K | 562K | 161.16M | -1K | n/a | n/a | 137K | 46K | 60.00 | 73.00 | 79.00 | 30.00 | 412.00 | -551 | 137.52K | 17.00 |
Net Cash Flow | -3.91M | 4.82M | 37.75M | -34.91M | n/a | -7.01M | -5.62M | 10.55M | -4.8M | -7.05M | 2.73M | 4.18M | -8.7M | -8.99M | 26.41M | -7.7M |
Free Cash Flow | -20.27M | -21.69M | -38.13M | -23.44M | n/a | -7.01M | -14.9M | -17.22M | -14.14M | -13.77M | -18.37M | -17.62M | -11.02M | -10.86M | -11.32M | -9.23M |